A detailed history of State Street Corp transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, State Street Corp holds 19,986 shares of AIKI stock, worth $75,946. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,986
Previous 19,986 -0.0%
Holding current value
$75,946
Previous $75,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$4.59 - $7.99 $91,735 - $159,688
19,986 New
19,986 $118,000

Others Institutions Holding AIKI

About AIkido Pharma Inc.


  • Ticker AIKI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,485,100
  • Market Cap $20.8M
  • Description
  • AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...
More about AIKI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.